Scanning laser polarimetry with variable corneal compensation and detection of glaucomatous optic neuropathy
The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes. Sixty-five healthy and 59 glaucomatous age-matched patients underwent...
Saved in:
Published in | Graefe's archive for clinical and experimental ophthalmology Vol. 243; no. 8; pp. 774 - 779 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Springer Nature B.V
01.08.2005
|
Subjects | |
Online Access | Get full text |
ISSN | 0721-832X 1435-702X |
DOI | 10.1007/s00417-004-1118-1 |
Cover
Loading…
Abstract | The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes.
Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values.
All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability.
SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40. |
---|---|
AbstractList | The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes. Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values. All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability. SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40. The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes. Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values. All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability. SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40. The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes.BACKGROUNDThe aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal compensator (VCC) to discriminate between healthy and glaucomatous eyes.Sixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values.METHODSSixty-five healthy and 59 glaucomatous age-matched patients underwent a complete ophthalmological evaluation, an achromatic automated perimetry (AAP), and SLP with GDx-VCC. One randomly selected eye from each subject was considered. All glaucomatous eyes had reproducible visual field defects. Mean values (+/- SD) of all SLP-VCC parameters measured in the two groups were compared. Area under receiver operating characteristics (AUROC) curve and sensitivities at predetermined specificities of >or=80% and >or=95% for each single parameter were calculated. Moreover, the nerve fiber indicator (NFI) diagnostic accuracy was evaluated calculating positive, negative, and interval likelihood ratios (LRs) at different cutoff values.All SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability.RESULTSAll SLP parameters were significantly different between the two groups (p<0.001). The NFI showed the best AUROC curve (0.938, SE 0.02) whereas temporal, superior, nasal, inferior, temporal (TSNIT) average was second best (0.897, SE 0.03), and normalized superior area was third (0.879, SE 0.04). At fixed specificity >or=95%, sensitivities ranged from 22% to 79.7% whereas for values >or=80%, sensitivities were in the 44.1-89.8% range. At a cutoff NFI value of 30, positive LR was 17.6 (95% CI: 5.8-53.6) and negative LR was 0.19 (95% CI: 0.11-0.33). Interval LRs for NFI showed that values <or=20 or >40 were associated with large effects on posttest probability.SLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40.CONCLUSIONSSLP-VCC allows good discrimination between healthy and glaucomatous eyes. New software-provided parameters NFI, TSNIT average, and normalized superior and inferior areas appear to be reliable in the evaluation of glaucomatous disease. In particular, after evaluation on interval LRs, the NFI showed a high diagnostic accuracy for values <or=20 or >40. |
Author | Da Pozzo, Stefano Ravalico, Giuseppe Iacono, Pierluigi Fantin, Anna Marchesan, Roberta |
Author_xml | – sequence: 1 givenname: Stefano surname: Da Pozzo fullname: Da Pozzo, Stefano – sequence: 2 givenname: Pierluigi surname: Iacono fullname: Iacono, Pierluigi – sequence: 3 givenname: Roberta surname: Marchesan fullname: Marchesan, Roberta – sequence: 4 givenname: Anna surname: Fantin fullname: Fantin, Anna – sequence: 5 givenname: Giuseppe surname: Ravalico fullname: Ravalico, Giuseppe |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15756574$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcFrFTEQxoNU7GvrH-BFggdvq5lkd7N7lNKqUPCghd7CvOyk3ZKXrElWef-9aV9F6MHLDMP8vmH4vhN2FGIgxt6A-ABC6I9ZiBZ0U2sDAEMDL9gGWtU1WsibI7YRWkIzKHlzzE5yvhcVVB28YsfQ6a7vdLth_rvFEOZwyz1mSnyJHtO8o5L2_Pdc7vivOuLWE7cxBUJf-26hkLHMMXAME5-okH2couO3HtdKYIlr5nEps-WB1hQXLHf7M_bSoc_0-qmfsuvLix_nX5qrb5-_nn-6aqySfWmc6yfV9wpcZ5XejlI7IOX6QZCjaetQEnYTCTGquu6s0ORGN4KU0INCVKfs_eHukuLPlXIxuzlb8h4D1b9MP3SqHduhgu-egfdxTaH-ZqQSehxkqyv09glatzuazFL9wbQ3f02sABwAm2LOidw_RJiHoMwhKFOreQjKQNXoZxo7l0dPS8LZ_0f5ByM5mVQ |
CitedBy_id | crossref_primary_10_1038_eye_2008_50 crossref_primary_10_1097_IJG_0b013e3180316754 crossref_primary_10_1111_j_1755_3768_2011_02133_x crossref_primary_10_1016_j_jaapos_2008_03_011 crossref_primary_10_1136_bjo_2008_145540 crossref_primary_10_1007_s10384_009_0717_0 crossref_primary_10_1016_j_survophthal_2013_04_007 crossref_primary_10_1097_IJG_0b013e318168f01a crossref_primary_10_1097_OPX_0b013e31824f164d crossref_primary_10_1007_s10384_010_0870_5 crossref_primary_10_1186_1471_2202_9_93 crossref_primary_10_1016_j_optm_2008_12_011 crossref_primary_10_1038_eye_2015_158 crossref_primary_10_1111_j_1442_9071_2008_01891_x crossref_primary_10_1002_14651858_CD008803_pub2 |
Cites_doi | 10.1001/archopht.1980.01020030486010 10.1016/S0002-9394(02)01512-X 10.1016/S0002-9394(00)00353-6 10.1016/S0161-6420(02)01899-7 10.1016/j.ophtha.2004.04.024 10.1167/iovs.03-0692 10.1001/archopht.119.7.985 10.1001/jama.1994.03510330081039 10.1167/iovs.02-0814 10.1001/archopht.1982.01030030137016 10.1016/S0002-9394(14)70993-6 10.1016/S0002-9394(02)02077-9 10.1016/S0002-9394(14)72726-6 10.1097/00061198-200008000-00001 10.1001/archopht.1991.01080010079037 10.1001/archopht.121.7.961 10.1001/archopht.120.7.901 10.1016/0895-4356(91)90128-V 10.3928/1542-8877-20020301-08 10.1167/iovs.03-0646 10.1016/j.ophtha.2003.05.015 10.1001/archopht.120.6.701 10.1001/archopht.122.6.827 10.1067/mem.2003.273 10.1016/S0161-6420(03)00479-2 10.1001/archopht.1990.01070060105058 |
ContentType | Journal Article |
Copyright | Springer-Verlag 2005 |
Copyright_xml | – notice: Springer-Verlag 2005 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 |
DOI | 10.1007/s00417-004-1118-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1435-702X |
EndPage | 779 |
ExternalDocumentID | 982194621 15756574 10_1007_s00417_004_1118_1 |
Genre | Journal Article |
GroupedDBID | --- -Y2 .55 .86 .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29I 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 4.4 406 408 409 40D 40E 53G 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8UJ 95- 95. 95~ 96X AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYXX AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACUDM ACZOJ ADBBV ADHIR ADHKG ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFHIU AFKRA AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ATHPR AXYYD AYFIA AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU CITATION COF CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 ZMTXR ZOVNA ~EX -53 -5E -5G -BR -EM -~C 3V. AAAVM ADINQ CGR CUY CVF ECM EIF GQ6 NPM Z7U Z81 Z82 Z83 Z87 Z8O Z8U Z8V Z8W Z91 7TK 7XB 8FK ABRTQ K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 |
ID | FETCH-LOGICAL-c326t-ff6d36631f5c37b927f1e3f680efedbfa2ea5de009337b5c07ef9f91221613aa3 |
IEDL.DBID | 7X7 |
ISSN | 0721-832X |
IngestDate | Thu Aug 07 14:25:15 EDT 2025 Thu Aug 14 17:30:59 EDT 2025 Wed Feb 19 01:39:00 EST 2025 Tue Jul 01 02:07:45 EDT 2025 Thu Apr 24 22:51:30 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c326t-ff6d36631f5c37b927f1e3f680efedbfa2ea5de009337b5c07ef9f91221613aa3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 15756574 |
PQID | 230798247 |
PQPubID | 48614 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_68534948 proquest_journals_230798247 pubmed_primary_15756574 crossref_primary_10_1007_s00417_004_1118_1 crossref_citationtrail_10_1007_s00417_004_1118_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-8-00 2005-Aug 20050801 |
PublicationDateYYYYMMDD | 2005-08-01 |
PublicationDate_xml | – month: 08 year: 2005 text: 2005-8-00 |
PublicationDecade | 2000 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Heidelberg |
PublicationTitle | Graefe's archive for clinical and experimental ophthalmology |
PublicationTitleAlternate | Graefes Arch Clin Exp Ophthalmol |
PublicationYear | 2005 |
Publisher | Springer Nature B.V |
Publisher_xml | – name: Springer Nature B.V |
References | RN Weinreb (1118_CR30) 2002; 120 EJ Gallagher (1118_CR6) 2003; 42 D Tannenbaum (1118_CR25) 2004; 111 C Bowd (1118_CR2) 2001; 42 C Bowd (1118_CR3) 2003; 121 NJ Reus (1118_CR19) 2004; 111 DS Greenfield (1118_CR8) 2002; 134 MA Kass (1118_CR11) 2002; 120 H Bagga (1118_CR1) 2003; 135 YY Chen (1118_CR4) 1998; 7 MJ Tjon-Fo-Sang (1118_CR26) 1997; 123 NJ Reus (1118_CR20) 2004; 45 JR Shields (1118_CR22) 2002; 33 DL Simel (1118_CR23) 1991; 44 JE Pederson (1118_CR16) 1980; 98 E Hodapp (1118_CR9) 1993 FA Medeiros (1118_CR15) 2004; 122 FA Medeiros (1118_CR14) 2003; 44 DS Greenfield (1118_CR7) 2000; 129 NJ Reus (1118_CR18) 2003; 110 LM Zangwill (1118_CR31) 2001; 119 RN Weinreb (1118_CR27) 1990; 108 RN Weinreb (1118_CR29) 2002; 120 NT Choplin (1118_CR5) 2003; 110 A Sommer (1118_CR24) 1991; 109 Q Zhou (1118_CR32) 2002; 43 RN Weinreb (1118_CR28) 1995; 120 YH Kwon (1118_CR13) 2000; 9 RW Knighton (1118_CR12) 2002; 43 PG Schlottmann (1118_CR21) 2004; 45 R Jaeschke (1118_CR10) 1994; 271 HA Quigley (1118_CR17) 1982; 100 12766063 - Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2606-12 12689893 - Ophthalmology. 2003 Apr;110(4):719-25 11942543 - Ophthalmic Surg Lasers. 2002 Mar-Apr;33(2):123-6 10926978 - Am J Ophthalmol. 2000 Jun;129(6):715-22 1987954 - Arch Ophthalmol. 1991 Jan;109(1):77-83 11773016 - Invest Ophthalmol Vis Sci. 2002 Jan;43(1):82-6 12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30 12860798 - Arch Ophthalmol. 2003 Jul;121(7):961-6 8309035 - JAMA. 1994 Mar 2;271(9):703-7 12583788 - Arch Ophthalmol. 2003 Feb;121(2):218-24 11481263 - Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1993-2003 15161846 - Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1823-9 12654370 - Am J Ophthalmol. 2003 Apr;135(4):521-9 7362506 - Arch Ophthalmol. 1980 Mar;98(3):490-5 15465547 - Ophthalmology. 2004 Oct;111(10):1860-5 7055464 - Arch Ophthalmol. 1982 Jan;100(1):135-46 2322159 - Arch Ophthalmol. 1990 Apr;108(4):557-60 12883522 - Ann Emerg Med. 2003 Aug;42(2):298-303 12091420 - Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2221-8 12917165 - Ophthalmology. 2003 Aug;110(8):1512-6 9786559 - J Glaucoma. 1998 Oct;7(5):312-6 15197057 - Arch Ophthalmol. 2004 Jun;122(6):827-37 10958600 - J Glaucoma. 2000 Aug;9(4):281-8 1941027 - J Clin Epidemiol. 1991;44(8):763-70 8540546 - Am J Ophthalmol. 1995 Dec;120(6):732-8 15019373 - Ophthalmology. 2004 Feb;111(2):259-64 12095804 - Am J Ophthalmol. 2002 Jul;134(1):27-33 11448320 - Arch Ophthalmol. 2001 Jul;119(7):985-93 14985299 - Invest Ophthalmol Vis Sci. 2004 Mar;45(3):840-5 9186098 - Am J Ophthalmol. 1997 Jan;123(1):62-9 12096960 - Arch Ophthalmol. 2002 Jul;120(7):901-6 |
References_xml | – volume: 98 start-page: 490 year: 1980 ident: 1118_CR16 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1980.01020030486010 – volume: 134 start-page: 27 year: 2002 ident: 1118_CR8 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(02)01512-X – volume: 129 start-page: 715 year: 2000 ident: 1118_CR7 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(00)00353-6 – volume: 43 start-page: 2221 year: 2002 ident: 1118_CR32 publication-title: Invest Ophthalmol Vis Sci – volume: 110 start-page: 719 year: 2003 ident: 1118_CR5 publication-title: Ophthalmology doi: 10.1016/S0161-6420(02)01899-7 – volume: 7 start-page: 312 year: 1998 ident: 1118_CR4 publication-title: J Glaucoma – volume: 111 start-page: 1860 year: 2004 ident: 1118_CR19 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2004.04.024 – volume: 45 start-page: 1823 year: 2004 ident: 1118_CR21 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.03-0692 – volume: 119 start-page: 985 year: 2001 ident: 1118_CR31 publication-title: Arch Ophthalmol doi: 10.1001/archopht.119.7.985 – volume: 271 start-page: 703 year: 1994 ident: 1118_CR10 publication-title: JAMA doi: 10.1001/jama.1994.03510330081039 – volume: 44 start-page: 2606 year: 2003 ident: 1118_CR14 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.02-0814 – volume: 100 start-page: 135 year: 1982 ident: 1118_CR17 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1982.01030030137016 – volume: 123 start-page: 62 year: 1997 ident: 1118_CR26 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(14)70993-6 – volume: 42 start-page: 1993 year: 2001 ident: 1118_CR2 publication-title: Invest Ophthalmol Vis Sci – volume: 135 start-page: 521 year: 2003 ident: 1118_CR1 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(02)02077-9 – volume: 120 start-page: 732 year: 1995 ident: 1118_CR28 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(14)72726-6 – volume: 9 start-page: 281 year: 2000 ident: 1118_CR13 publication-title: J Glaucoma doi: 10.1097/00061198-200008000-00001 – volume: 109 start-page: 77 year: 1991 ident: 1118_CR24 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1991.01080010079037 – volume: 121 start-page: 961 year: 2003 ident: 1118_CR3 publication-title: Arch Ophthalmol doi: 10.1001/archopht.121.7.961 – volume: 120 start-page: 218 year: 2002 ident: 1118_CR29 publication-title: Arch Ophthalmol doi: 10.1001/archopht.120.7.901 – volume: 44 start-page: 763 year: 1991 ident: 1118_CR23 publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(91)90128-V – volume: 33 start-page: 123 year: 2002 ident: 1118_CR22 publication-title: Ophthalmic Surg Lasers doi: 10.3928/1542-8877-20020301-08 – start-page: 52 volume-title: Clinical decisions in glaucoma year: 1993 ident: 1118_CR9 – volume: 43 start-page: 82 year: 2002 ident: 1118_CR12 publication-title: Invest Ophthalmol Vis Sci – volume: 45 start-page: 840 year: 2004 ident: 1118_CR20 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.03-0646 – volume: 111 start-page: 259 year: 2004 ident: 1118_CR25 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2003.05.015 – volume: 120 start-page: 701 year: 2002 ident: 1118_CR11 publication-title: Arch Ophthalmol doi: 10.1001/archopht.120.6.701 – volume: 122 start-page: 827 year: 2004 ident: 1118_CR15 publication-title: Arch Ophthalmol doi: 10.1001/archopht.122.6.827 – volume: 42 start-page: 298 year: 2003 ident: 1118_CR6 publication-title: Ann Emerg Med doi: 10.1067/mem.2003.273 – volume: 110 start-page: 1512 year: 2003 ident: 1118_CR18 publication-title: Ophthalmology doi: 10.1016/S0161-6420(03)00479-2 – volume: 120 start-page: 901 year: 2002 ident: 1118_CR30 publication-title: Arch Ophthalmol doi: 10.1001/archopht.120.7.901 – volume: 108 start-page: 557 year: 1990 ident: 1118_CR27 publication-title: Arch Ophthalmol doi: 10.1001/archopht.1990.01070060105058 – reference: 11481263 - Invest Ophthalmol Vis Sci. 2001 Aug;42(9):1993-2003 – reference: 10958600 - J Glaucoma. 2000 Aug;9(4):281-8 – reference: 8540546 - Am J Ophthalmol. 1995 Dec;120(6):732-8 – reference: 7362506 - Arch Ophthalmol. 1980 Mar;98(3):490-5 – reference: 15197057 - Arch Ophthalmol. 2004 Jun;122(6):827-37 – reference: 1941027 - J Clin Epidemiol. 1991;44(8):763-70 – reference: 11942543 - Ophthalmic Surg Lasers. 2002 Mar-Apr;33(2):123-6 – reference: 12095804 - Am J Ophthalmol. 2002 Jul;134(1):27-33 – reference: 12049574 - Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30 – reference: 12766063 - Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2606-12 – reference: 15019373 - Ophthalmology. 2004 Feb;111(2):259-64 – reference: 8309035 - JAMA. 1994 Mar 2;271(9):703-7 – reference: 2322159 - Arch Ophthalmol. 1990 Apr;108(4):557-60 – reference: 1987954 - Arch Ophthalmol. 1991 Jan;109(1):77-83 – reference: 11773016 - Invest Ophthalmol Vis Sci. 2002 Jan;43(1):82-6 – reference: 12883522 - Ann Emerg Med. 2003 Aug;42(2):298-303 – reference: 12096960 - Arch Ophthalmol. 2002 Jul;120(7):901-6 – reference: 12091420 - Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2221-8 – reference: 11448320 - Arch Ophthalmol. 2001 Jul;119(7):985-93 – reference: 15465547 - Ophthalmology. 2004 Oct;111(10):1860-5 – reference: 12917165 - Ophthalmology. 2003 Aug;110(8):1512-6 – reference: 12860798 - Arch Ophthalmol. 2003 Jul;121(7):961-6 – reference: 9786559 - J Glaucoma. 1998 Oct;7(5):312-6 – reference: 9186098 - Am J Ophthalmol. 1997 Jan;123(1):62-9 – reference: 12654370 - Am J Ophthalmol. 2003 Apr;135(4):521-9 – reference: 15161846 - Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1823-9 – reference: 14985299 - Invest Ophthalmol Vis Sci. 2004 Mar;45(3):840-5 – reference: 10926978 - Am J Ophthalmol. 2000 Jun;129(6):715-22 – reference: 12583788 - Arch Ophthalmol. 2003 Feb;121(2):218-24 – reference: 12689893 - Ophthalmology. 2003 Apr;110(4):719-25 – reference: 7055464 - Arch Ophthalmol. 1982 Jan;100(1):135-46 |
SSID | ssj0004351 |
Score | 1.8407123 |
Snippet | The aim of this study was to evaluate the ability of scanning laser polarimetry (SLP) parameters provided by commercially available GDx with variable corneal... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 774 |
SubjectTerms | Aged Area Under Curve Birefringence Cornea - physiology Diagnostic Techniques, Ophthalmological False Negative Reactions Glaucoma - diagnosis Humans Intraocular Pressure Lasers Middle Aged Ophthalmology Optic Nerve Diseases - diagnosis Predictive Value of Tests ROC Curve Sensitivity and Specificity Vision Disorders - diagnosis Visual Field Tests Visual Fields |
Title | Scanning laser polarimetry with variable corneal compensation and detection of glaucomatous optic neuropathy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15756574 https://www.proquest.com/docview/230798247 https://www.proquest.com/docview/68534948 |
Volume | 243 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA4-QLyIb9dnDp6EYNu0TXuSXXERwUV8wN5KmkxA0O66WwX_vTNpdxcPemkpTVrIJJNvHvmGsXMZ5Dq3ygqpTSLiFBJRyiwQRkmQ0sUqMeTvuB-kty_x3TAZtrk50zatcqYTvaK2I0M-8ktKWM6zKFZX4w9BRaMouNpW0Fhmq8RcRhldaqgWxyKlr75IDGACJ-5wFtQMGg5RVM-etA8htgh_b0t_YE2_5_Q32UYLFnm3ke4WW4Jqm63dt-HwHfb2ZJqSQxwxMEz4mOzU13eoJ9-cHKz8Cx_pbBRHG7NCSMgpgxwNVy8OrivLLdQ-GaviI8cRSn9iCyqTPuUjVCaGe75LKlv8vcte-jfP17eiLZ8gDGKyWjiXWomAInSJkarMI-VCkC7NAnBgS6cj0IkF79NQZWICBS53eRhFiAKl1nKPrVSjCg4Y9-G8MDOhUxAbVWLr1IRWg9V5ZLOww4LZ6BWm5RanEhdvxZwV2Q94gVeyObICu1zMu4wbYo3_Gh_NRFK0a2xazGdEh53N3-LioIiHrgBHqkgRjBD_TYftN3Jc_Aphapqo-PDfLx-xdU_V6hP-jtlKPfmEEwQhdXnqp9opW-32e70B3ns3g4fHH1m13hY |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEBRol1LqA1yQLJI4iZMDqvrU9rErBK20t-DYY6lSyS67KWh_VP9jx06yVQ_trZdIUWxHGo8933jG3wB8FkGuciMNF0onPE4x4aXIAq6lQCFsLBPtzjuGo3RwEZ-Mk_EK3HR3YVxaZbcn-o3aTLQ7I__mEpbzLIrlzvQvd0WjXHC1q6DRaMUpLv6Txzb_fnxA0_slio4Oz_cHvC0qwDUhlZpbmxpBZja0iRayzCNpQxQ2zQK0aEqrIlSJQe_pyzLRgUSb2zyMIsJGQilB4z6D1ViQJ9OD1b3D0Y-fdxcxha_36DjHOC2VcRdGDRrWUjIIniaQQD0P7xvCB9Ctt3JHr-FVC0_ZbqNPb2AFqzV4PmwD8G_h6pduihwxQt04Y1PnGV_-wXq2YO5Il_2jV3cbi5FXWxEIZS5nnVxlrwBMVYYZrH36V8UmlhF4v6YWrjD7nE1o-9LMM2y6QsmLd3DxJLJ9D71qUuEGMB9ADDMdWomxliW1TnVoFBqVRyYL-xB00it0y2buimpcFUseZi_wgp7Oy8kK6vJ12WXaUHk81nizm5KiXdXzYqmDfdhefqXl6GIsqkKSVJES_HGMO31Yb-bx7lcEjNNExh8eHXkbXgzOh2fF2fHodBNeeqJYn274EXr17Bq3CALV5adW8Rj8fmpdvwXkqho2 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIlVcEN8sBeoDXJCsJnEcJweEEGXVUlohQaW9BcceS5VKdtlNQfvT-HfMOMlWHOitl0hRbEcaz9hvPOM3AK9UUtnKGy-VdVrmBWrZqDKRzihUKuRGOz7vODktDs_yTzM924I_410YTqsc18S4UPu54zPyfU5YrsosN_thyIr4cjB9t_gpuYAUB1rHahq9hhzj-jd5b6u3Rwc01a-zbPrx24dDORQYkI5QSydDKLyiLTcN2inTVJkJKapQlAkG9E2wGVrtMXr9ptEuMRiqUKVZRjhJWato3Ftw2yidsomZmbm6kqli5UdmH5NkNLMxoJr0_KW0NUTCQIL3Mv13S_wPzo373fQe3B2Aqnjfa9Z92ML2AeycDKH4h3Dx1fXljgThb1yKBfvI5z-wW64FH-6KX_TK97IE-bctwVHB2evkNEdVELb1wmMXE8FaMQ-CYPwlteAS7Ssxp4XMici1ySWT14_g7EYk-xi223mLT0HEUGJaujQYzJ1pqHXhUm_R2yrzZTqBZJRe7QZecy6vcVFvGJmjwGt6sr9T1tTlzabLoif1uK7x7jgl9WDfq3qjjRPY23wlw-Roi22RJFUXBISYe2cCT_p5vPoVQeRCm_zZtSPvwQ5peP356PR4F-5ExtiYd_gctrvlJb4gLNQ1L6PWCfh-02r-F_FvHQY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Scanning+laser+polarimetry+with+variable+corneal+compensation+and+detection+of+glaucomatous+optic+neuropathy&rft.jtitle=Graefe%27s+archive+for+clinical+and+experimental+ophthalmology&rft.au=Da+Pozzo%2C+Stefano&rft.au=Iacono%2C+Pierluigi&rft.au=Marchesan%2C+Roberta&rft.au=Fantin%2C+Anna&rft.date=2005-08-01&rft.issn=0721-832X&rft.eissn=1435-702X&rft.volume=243&rft.issue=8&rft.spage=774&rft.epage=779&rft_id=info:doi/10.1007%2Fs00417-004-1118-1&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s00417_004_1118_1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0721-832X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0721-832X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0721-832X&client=summon |